Press coverage about RTI Surgical (NASDAQ:RTIX) has trended somewhat positive this week, Accern Sentiment Analysis reports. Accern identifies negative and positive media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. RTI Surgical earned a media sentiment score of 0.24 on Accern’s scale. Accern also assigned news articles about the medical equipment provider an impact score of 45.263980990034 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
Shares of RTI Surgical (RTIX) opened at $4.50 on Wednesday. RTI Surgical has a 52-week low of $3.01 and a 52-week high of $6.00. The stock has a market cap of $270.70, a price-to-earnings ratio of -64.29, a PEG ratio of 1.98 and a beta of 1.71. The company has a quick ratio of 1.21, a current ratio of 3.34 and a debt-to-equity ratio of 0.25.
Several equities research analysts have recently issued reports on RTIX shares. Zacks Investment Research raised shares of RTI Surgical from a “sell” rating to a “hold” rating in a research report on Friday, October 13th. BidaskClub lowered shares of RTI Surgical from a “hold” rating to a “sell” rating in a research report on Tuesday, December 5th.
RTI Surgical Company Profile
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.